SYLENTIS
Biotechnology Research
Es
52 employees
- Employees
- 52
- Contacts
- 1
- Emails
- 1
- Phones
- 1
SYLENTIS Overview
- Headquarters
- Es
- Phone Number
- Available in AeroLeads
- Website
- sylentis.com
- Industry
- Biotechnology Research
- Employees
- 52
- Founded
- 2006
- Funding
- 24.7M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About SYLENTIS
Sylentis is an European biotechnological company founded in 2006. Sylentis focuses on researching new therapeutic approaches based on gene silencing. Our company is specialised in developing ophtalmologic therapies via interference RNA, a powerful tool for rational drug design. Most advanced product of the company are treatments for glaucoma and dry eye syndrome. Sylentis is a wholly owned member of PharmaMar (www.pharmamar.com)
SYLENTIS Contact Details
- People in AeroLeads
- 3
- With contact data
- 1
- Email contacts
- 1
- 33.3% coverage
- Phone contacts
- 1
- 33.3% coverage
SYLENTIS Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Lola Company Mateos | Director of Operations Sylentis |
View
|
|
| Marina Alonso Sanchez | Triple Master in Risk Prevention, Quality and Environment Management. European Quality Formation |
View
|
|
| Andreas Segerros | Antibes, Provence-alpes-côte D'azur, France |
Email
Phone
|
Employees by Management Level
Individual contributor
6 profiles
Director
1 profile
Manager
1 profile
Compare Similar Companies to SYLENTIS
Laboratorios Normon
Pharmaceutical Manufacturing
PharmaMar
Biotechnology Research
Oryzon Genomics SA
Biotechnology
Amadix
Biotechnology Research
ALGENEX S.L
Biotechnology Research
Nostrum Biodiscovery
Biotechnology
ARTHEx Biotech
Biotechnology Research
Vivia Biotech
Biotechnology
Nanovex Biotechnologies
Research Services
OLIGOFASTX
Biotechnology Research